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The filamentous mould Rhizopus microsporus is a member of the
zygomycetes (lower fungi). While some strains serve as food
fermenting fungi, others represent infamous plant pathogens and
opportunistic human pathogens. Recently, it was shown that some
strains of R. microsporus are associated with symbiotic bacteria. Here,
weoutlinewhytheseorganismsareimportantforhumanhealthand
how they can be exploited for drug development. Furthermore, we
illustrate what the investigation of bacterial–fungal symbiosis can
teach us about the evolution of pathogenicity factors in general.
Rhizopus microsporus Harbors Bacterial
Endosymbionts as Intracellular Toxin Factories
R. microsporus (ATCC 62417) attacks rice plants and illicits rice
seedling blight, a severe crop disease affecting rice fields in Asia
[1]. Symptoms of the infection include abnormal swelling of the
roots and finally death of the affected tissue. Plant pathogenic R.
microsporus strains live as necrotrophic pathogens, i.e., they derive
energy from killed host cells. For that purpose they secrete
rhizoxin (see Figure 1A), a toxin that blocks mitosis in eukarytotic
cells by binding to b-tubulin [2]. Rhizopus itself is resistant to the
toxin due to an amino acid exchange in the tubulin protein [3].
The production of toxins by plant pathogenic fungi is a widespread
virulence mechanism [4]. In the case of R. microsporus, however, the
search for biosynthetic genes coding for rhizoxin biosynthesis led
to an unexpected discovery: it is not the fungus itself that produces
the pathogenicity factor rhizoxin. Instead, the fungus harbors
bacterial symbionts, which are the actual producers of the
virulence factor [1]. Toxin formation by bacteria has been
demonstrated in analogy with Koch’s postulates in classical
microbiology: it was discovered that rhizoxin-producing strains
of R. microsporus contained symbionts, while nontoxinogenic strains
did not. Removal of symbionts by antibiotics indeed abolished
rhizoxin production. The bacteria could be isolated and grown in
axenic (pure) culture. Finally, reintroduction into cured hosts
clearly reestablished rhizoxin production [1]. Intriguingly, micro-
scopic investigations revealed that the bacteria are true endosym-
bionts, i.e., they inhabit the intracellular space of fungal mycelium
(see Figure 1B). The first endosymbiont of R. microsporus that could
be isolated was named Burkholderia rhizoxinica for its capability to
produce rhizoxin [5].
A New Role for Endobacteria in Mycotoxin
Research and Food Safety
The discovery of endobacteria as producers of ‘‘mycotoxins’’
was relevant in the areas of natural product research and
microbiology, since similar symbionts in other antibiotic producing
fungi might have been overlooked in the past [6]. Indeed, another
dangerous ‘‘mycotoxin’’, rhizonin (see Figure 1C), originally
isolated from R. microsporus (CBS 112285) is produced by
endobacteria as well [7]. These endobacteria are related to B.
rhizoxinica, but represent another species, Burkholderia endofungorum
[5]. Rhizonin is a cyclopeptide, which is highly toxic for mammals.
Tested animals exhibited serious hepatic lesions and died from
chronic failure of the liver [8]. The fact that the producing strain
was found on ground nuts in Mozambique underlines the
relevance of the Burkholderia–Rhizopus symbiosis for food safety
and human health. Concerning food safety, it is even more
distressing that another Burkholderia–Rhizopus association was
isolated from a tempe/sufu starter culture in Vietnam [1].
Tempe and sufu are traditional soy preparations in Asia that are
fermented with R. microsporus. It could be demonstrated that
rhizoxin is indeed produced during sufu fermentation, thus
revealing a potential threat to human health [9].
Endosymbionts of Rhizopus Were Detected in
Human Pathogens but Are Not Essential for
Zygomycoses
Rhizopus species including R. microsporus are regularly involved in
zygomycoses(mucormycoses),disastrousfungalinfectionsthataffect
immunocompromised patients. These diseases have high mortality
rates [10] and are hard to treat by antifungal agents. Consequently,
surgical debridement of infected tissue is often necessary [11]. After
the discovery of B. rhizoxinica it was speculated whether toxin
productionbyendosymbiontsmightenhancethe virulenceoffungal
strains involved in human disease. The bacteria would then provide
a promising target for the treatment of Rhizopus infections. Indeed, it
has been shown that rhizoxin-producing strains are frequently
involved in zygomycosis [11].
However, several lines of evidence suggest that rhizoxin
production seems not to be essential for Rhizopus pathogenicity
[11,12]. First of all, clinical cases of zygomycosis are frequently
caused by non-toxinogenic Rhizopus species [12]. Furthermore,
when R. microsporus was cured from symbionts with antibiotics, it
still retained its ability to infect mice under laboratory conditions
[11]. Although these results show that endosymbionts are not the
key players in zygomycosis, they might still raise the potential
health threat caused by R. microsporus: it is well conceivable that
endosymbionts that are released from fungal mycelium might
cause sepsis or further complications. In particular, B. rhizoxinica
and B. endofungorum could cause potential long-term damage by
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Burkholderia strains have been isolated from clinical specimen
[13]. Consequently, the existence of toxinogenic endosymbionts
should be kept in mind when it comes to treatment of zygomycosis.
Investigation of Rhizoxin Biosynthesis Can
Promote Antitumor Therapy
Despite all theses dangers emanating from toxin-producing
Rhizopus/Burkholderia strains, rhizoxin could also assist in antitumor
therapy: due to its ability to block mitosis via binding to b-tubulin,
rhizoxin exhibits strong activity against tumor cell lines in vitro [14].
The substance has already tested in phase II clinical trials [15].
However, its in vivo activity was unsatisfactory, probably due to low
activity and rapid elimination from plasma [15], and thus it would
be desirable to produce more potent derivatives. Rhizoxin belongs
to the family of macrolide antibiotics (as e.g., erythromycin) and is
produced by a modular polyketide synthase. The enzymatic
assembly line catalyzes repetitive condensation of activated acetate
(acetyl-CoAand malonyl-CoA)units,inasimilarwayasinfattyacid
biosynthesis [16]. In contrast to the latter, polyketide biosynthesis
allows for variable degrees of chain processing, and the polyketide
backbone is further modified by tailoring enzymes. Through genetic
manipulation of the biosynthesis genes it is possible to engineer
polyketide biosynthesis, and thus create new derivatives. Indeed, it
was possible to identify the genes coding for rhizoxin biosynthesis
[17] and to modify these genes in isolated symbionts. Thus, the
function of some enzymes could be investigated in detail [18,19].
Furthermore, it is promising that cultivation of B. rhizoxinica in pure
culture could significantly increase the yield of rhizoxin production
and lead to the isolation of new, significantly more active rhizoxin
derivatives [20].
Endosymbionts of Rhizopus: Former Pathogens of
Pathogens?
From a biologist’s point of view, the Burkholderia–Rhizopus
symbiosis has some intriguing aspects that go beyond zygomycosis
and natural product research. For instance, the question was raised
as to how the association between Rhizopus and Burkholderia has
evolved and how it is maintained. Microscopic investigations with
GFP-labeled endobacteria revealed that endosymbionts enter
fungal spores to be ‘‘inherited’’ during vegetative reproduction
[21]. Intriguingly, the reproduction of the host has been hijacked by
the symbionts: the host is unable to sporulate when endosymbionts
are removed [21]. Thus, they ensure their own propagation
alongside the host lineage (vertical transmission, see Figure 1C). In
addition, endobacteria are able to infect compatible host organisms
in laboratory cultures [22]. Spread of symbionts by release and
infection of another host is called horizontal transmission (see
Figure 1C). Both vertical and horizontal transmission could be
shown to be relevant during evolution of the Burkholderia–Rhizopus
alliance: comparison of phylogenetic trees of host strains and the
corresponding symbiont strains revealed that the topologies of these
trees resemble each other [23]. This means that host fungi and
symbiontshave undergone ‘‘cospeciation’’—symbiont lineageshave
been associated with their fungal host lineage over a long period of
time.However,somehostswitchingeventscouldbedetected,which
Figure 1. Chemical and biological features of endofungal bacteria. (A) Chemical structures of rhizoxin, an antimitotic macrolide, and rhizonin
A, a hepatotoxic cyclopeptide. (B) Light micrograph of a sporangium of R. microsporus (ATCC 62147) stained with a viability assay system (Invitrogen).
Green spots are living cells of the bacterial endosymbiont B. rhizoxinica. (C) Life cycle of R. microsporus strains and their endosymbionts B. rhizoxinica
and B. endofungorum. Endobacteria are propagated within fungal spores (vertical transmission). Under laboratory conditions, isolated bacteria can
infect compatible host strains (horizontal transmission).
doi:10.1371/journal.ppat.1002096.g001
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endosymbionts have actually evolved from former parasites
(pathogens) of Rhizopus. It looks like both partners benefit from
their close relationship: while the fungus obtains powerful chemical
weapons produced by B. rhizoxinica, the latter is supplied with
nutrients and a safe niche. Any mutually beneficial symbiosis is
called mutualism. However, the line between mutualism and
parasitism is thin and shifts might occur during evolution. This
parasitism–mutualism shift hypothesis is further supported by
genome sequencing of B. rhizoxinica [24,25]: while the genome
retains only a reduced number of genes compared to free-living
Burkholderia species, it encodes a large repertoire of typical virulence
factors. It could be demonstrated that a type III secretion system
(T3SS) [22] and the lipopolysaccharide O-antigen [26] are essential
to maintain the symbiosis. Both factors are known pathogenicity
factors of animal and plant pathogens. T3SSs are giant protein
export machineries anchored in both membranes of Gram-negative
bacteria (see Figure 2A). Usually, they accomplish export of effector
proteins that manipulate cellular processes of the host [27].
Symbionts lacking these systems are unable to reinfect their host
fungus and cannot illicit its sporulation like the wild type [22].
Similar results were obtained for mutants lacking the O-antigen—a
long polysaccharide chain anchored in the outer membrane (see
Figure 2B) [26]. It is plausible that the O-antigen is needed for
protection against fungal defense mechanisms or recognition of the
symbionts.
These results teach us that bacterial symbionts of fungi employ
similar factors as plant parasites or human pathogens. These
mechanisms seem to be universal host control tools that can be
adapted to highly versatile hosts and cellular targets.
Figure 2. Symbiosis factors of B. rhizoxinica. (A) The role of the type III secretion system (T3SS) in bacterial–fungal symbiosis. T3SSs consist of
several ring-like structures anchored in both the outer (OM) and inner membrane (IM) of Gram-negative bacteria. Energy is derived from an ATPase
component situated at the cytosolic side of the protein complex. Effector proteins are secreted through a pilus structure into host cells. When key
components are inactivated, mutants fail to reinfect the host. (B) Role of the lipopolysaccharide (LPS) in bacterial–fungal symbiosis. LPS molecules are
anchored in the outer membrane of Gram-negative bacteria by their lipid component (lipid A). The sugar components form a heterogeneous core
oligosaccharide and a polymeric O-antigen. When the O-antigen is missing, mutants reinfect the host sporadically, but are incapable of establishinga
stable symbiosis.
doi:10.1371/journal.ppat.1002096.g002
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